{
    "nctId": "NCT05711030",
    "briefTitle": "Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery",
    "officialTitle": "Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery: Single-Injection Versus Multiple Injections. A Randomized Controlled Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasms, Breast Neoplasm Female, Cancer, Breast, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 68,
    "primaryOutcomeMeasure": "Total perioperative fentanyl (mcg) consumption",
    "eligibilityCriteria": "Inclusion Criteria:\n\n\u2022 Patients \\> 18 years old with American Society of Anaesthesiologists (ASA) status I-III, BMI\\<35, undergoing partial or total mastectomies without axillary lymph node dissection\n\nExclusion Criteria:\n\n* \\< 18 years old\n* Body mass index (BMI) \\> 35\n* Body weight under 50 kg\n* Obstructive sleep apnea (moderate to severe)\n* Unable to communicate with the investigators\n* Receiving anticoagulation or experiencing any bleeding disorder\n* Known allergy to local anesthetics, fentanyl or hydromorphone\n* Active infection at injection sites\n* Preexisting neurological deficit or psychiatric illness\n* Severe cardiovascular disease\n* Liver failure\n* Renal failure (estimated glomerular filtration rate \\<15 mL/ min/1.73 m2)\n* Pregnancy\n* Arrhythmia (NOL monitoring cannot be used reliably)\n* Technical inability to proceed with the blocks\n* History of chronic pain with daily opioid use during the 3 months before surgery\n* Patient refusal",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}